28457 – EPIDEMIOLOGICAL AND CLINICOPATHOLOGICAL PARAMETERS ASSOCIATED WITH NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER DURING THE COVID-19 PANDEMIC

Authors

  • Maria Fernanda da Motta Sperotto Valadares Gontijo
  • Letícia Martins de Araújo Campos Linhares
  • Luísa Lazarino de Souza Campos
  • Marcela de Oliveira Sá
  • Caroline Cançado Avelar

DOI:

https://doi.org/10.29289/259453942024V34S2037

Abstract

Introduction:

Breast cancer is a complex and heterogeneous disease. Its socioeconomic aspects have been recognized as determinants
of clinical outcomes. The COVID-19 crisis negatively affected millions of people, especially in impoverished macro-regions
such as Brazil. Conclusion: This study demonstrated the impacts of the COVID-19 pandemic on the patient’s journey
with breast cancer. During this period of interruptions in healthcare services, the disease presented at more advanced
stages, but the complete pathological response (pCR) was higher than expected, and the influence on chemotherapy decisions was not significant. Overall, efforts were made to ensure patients received the best targeted care for breast cancer.

Downloads

Download data is not yet available.

Downloads

Published

2026-02-27

How to Cite

Gontijo, M. F. da M. S. V., Linhares, L. M. de A. C., Campos, L. L. de S., Sá, M. de O., & Avelar, C. C. (2026). 28457 – EPIDEMIOLOGICAL AND CLINICOPATHOLOGICAL PARAMETERS ASSOCIATED WITH NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER DURING THE COVID-19 PANDEMIC. Mastology, 34(suppl.2). https://doi.org/10.29289/259453942024V34S2037

Issue

Vol. 34 No. suppl.2 (2024)

Section

Abstract

License

Copyright (c) 2026 Maria Fernanda da Motta Sperotto Valadares Gontijo, Letícia Martins de Araújo Campos Linhares, Luísa Lazarino de Souza Campos, Marcela de Oliveira Sá, Caroline Cançado Avelar

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.